Misplaced Pages

Carbaldrate: Difference between revisions

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 15:02, 12 May 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (← Previous edit Revision as of 07:32, 3 September 2011 edit undoBogBot (talk | contribs)Bots53,132 edits populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBotNext edit →
Line 1: Line 1:
{{Drugbox {{Drugbox
| verifiedrevid = 387474044 | verifiedrevid = 387474044
| IUPAC_name = | IUPAC_name =
| image = | image =

⚫ | CAS_number =
<!--Clinical data-->
⚫ | ATC_prefix = A02
| ATC_suffix = AB04 | tradename =
| PubChem = | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| DrugBank = | pregnancy_US = <!-- A / B / C / D / X -->
| chemical_formula = | pregnancy_category =
⚫ | legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
⚫ | molecular_weight =
⚫ | legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| bioavailability =
⚫ | legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
⚫ | protein_bound =
⚫ | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
⚫ | metabolism =
⚫ | legal_status =
⚫ | elimination_half-life =
⚫ | routes_of_administration =
⚫ | excretion =

| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
<!--Pharmacokinetic data-->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category= | bioavailability =
⚫ | protein_bound =
⚫ | legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
⚫ | metabolism =
⚫ | legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
⚫ | elimination_half-life =
⚫ | legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
⚫ | excretion =
⚫ | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->

⚫ | legal_status =
<!--Identifiers-->
⚫ | routes_of_administration =
⚫ | CAS_number =
⚫ | ATC_prefix = A02
| ATC_suffix = AB04
| PubChem =
| DrugBank =

<!--Chemical data-->
| chemical_formula =

⚫ | molecular_weight =
}} }}
'''Dihydroxialumini sodium carbonate''' is an ]. '''Dihydroxialumini sodium carbonate''' is an ].

Revision as of 07:32, 3 September 2011

Pharmaceutical compound
Carbaldrate
Clinical data
ATC code
Identifiers
CompTox Dashboard (EPA)
  (verify)

Dihydroxialumini sodium carbonate is an antacid.

It is also known as "dihydroxyaluminium sodium carbonate".

References

  1. Długaszek M, Fiejka MA, Graczyk A, Aleksandrowicz JC, Slowikowska M (2000). "Effects of various aluminium compounds given orally to mice on Al tissue distribution and tissue concentrations of essential elements". Pharmacol. Toxicol. 86 (3): 135–9. doi:10.1034/j.1600-0773.2000.d01-25.x. PMID 10752672. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Drugs for acid related disorders: Antacids (A02A)
Magnesium (increases motility)
Aluminium (decreases motility)
Calcium
Sodium
Combinations and complexes
of aluminium, calcium and magnesium


Stub icon

This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it.

Categories:
Carbaldrate: Difference between revisions Add topic